Garity v. Tetraphase Pharmaceuticals, Inc.

CourtDistrict Court, S.D. New York
DecidedMay 30, 2019
Docket1:18-cv-06797
StatusUnknown

This text of Garity v. Tetraphase Pharmaceuticals, Inc. (Garity v. Tetraphase Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Garity v. Tetraphase Pharmaceuticals, Inc., (S.D.N.Y. 2019).

Opinion

UNITESDT ATEDSI STRICCOTU RT USDSCDNY SOUTHEDRINS TRIOCFNT E WY ORK DOCUMEENLTE CTRONICALLY FILED --------------------------DO-C-#--:-- ------- -- ----------- EDWARGDA RITIYn,d iviadnuodan l ly DATFEI LED..-:_ ?o -/7 BehaolfAf lO lt hers SSiimtiulaatreldy, Pliantfi,f -against- 1:18-cv(-A0L6C7)9 7 TETRAPHPAHSAER MACEUTICALS OPINI&O ONR DER INCG.U,Y M ACDONALJDA,C QUES DUMASP,I PEJRA FFR&A CYO .B,M O CAPITMAALR KETCSO RPS.T,I FEL NICOLA&U CSO .I,N CS.U,N TRUST ROBINSHOUNM PHRE&Y C O.L,L C, anHd. CW.A INWRIG&H CTO .L,L C, Defendants. -------------------------------------------- ANDRELW.C ARTEJRR,U. n,i tSetdaD tiesst Jruidcgte : PlaiEndtwiaGffra dr birtiytn hgsises c urliittiiaeggsaa tiDineosfnte nTdeatnrtasp hase PharmaceIun(tc"i.Tc eatlrsoa,rtp hh"eaC soem"p aGnuyMy"a )c,d oJnaaclqdDu,ue msaP si,p er Jaffr&a CyoB .M,O C apiMtaarlkC eotrpsS. t,i Nfeilc o&l CaouI.sn, Sc u.n,T Rroubsitn son Humph&r CeoyL. L,C a,n Hd. CW.a inwr&i CgoLh.Lt,C ( colle"cDteifevnedlaoynn,t s"), behaalp fu ropfoc rltaoesfids n ve1sS teoEerC sF. No.p1l,. "".C om Nowb eftohrCeeo uarrDtee fendMaonttitsooT'n r antshfecera tsote h Uen ited States DistCroiufocrrttt h Dei storfMi acsts achusetotfMs a s(s"aDcihsutsreittcto2ts8 " ) pursua U.S§.1 C4.0 4a(naad) moftiilboeynLd a iTlhao mptsobo ean p poianslt eepadld a intiff purstuota hnPetr ivSaetceu ritieRse fLoAirctomtif 1 g 9a91t55iU, o. nS §.7 C7.z -l(Fao)r( 3). thfoel lowingt hrmeeo atsitoootnn rs a,ni sgsfer ra natntedhd me o titooan p poali enpatld a intiff 1 DefenPdiapnJetarsf f&r CaoBy.M ,O C apiMtaarlkC eotrsSp t.i,Nf ieclo &lC aouI.sn, cS .u,n TRroubsitn son Humph&r CeoyL. L,C a.n,Wd a inwr&iC goLh.Lt,C a rceo llercetfievtreohrl eeyrd e iansta hftee r" Underwriter Defendants". is denied without prejudice. BACKGROUND In July 2017, Tetraphase and its officers raised $61.1 million through a secondary public offering (“SPO”) to fund IGNITE3, a clinical trial to test the efficacy and safety of the Company’s lead product candidate, eravacycline. Compl. § 21. The Underwriter Defendants served as underwriters for the SPO. Id. ¥ 8 Plaintiff alleges that Defendants made false and misleading statements about Tetraphase’s business and operations. Jd. {| 1. The Complaint also alleges that venue is proper in the United States District Court for the Southern District of New York (“SDNY”) because all Underwriter Defendants maintain offices and substantial operations in this District, the remaining three Defendants conducted an offering within this District, and Tetraphase’s stock trades on an exchange that operates within this District. Id. 8. On October 9, 2018, Defendants filed a motion to transfer this case to the District of Massachusetts. ECF No. 19. Defendants argue the District of Massachusetts is more appropriate because: 1) Tetraphase is headquartered in Massachusetts; 2) the individual defendants reside and work in Massachusetts; 3) most of the potentially relevant documents and witnesses are in Massachusetts; and 4) Tetraphase issued the challenged statements from Massachusetts. ECF No. 20. On October 23, 2018, Plaintiff filed an opposition to the motion to transfer; arguing that Plaintiff's choice of forum should be given significant deference and Defendants failed to present “clear and convincing evidence” to overcome that deference. LEGAL STANDARD District courts may transfer a civil action “[flor the convenience of the parties and witnesses, in the interest of justice.” See 28 U.S.C. § 1404(a); Semente v. Empire Healthchoice

Assurance, Inc., 2014 WL 4967193, at *1 (S.D.N.Y. Sept. 29, 2014) (“Even if venue is proper ... the Court may still transfer the case to a more appropriate forum pursuant to Section 1404(a)”). On a motion to transfer, “the burden is on the movant to show that the transfer is justified... Absent a clear and convincing showing that the balance of convenience strongly favors the alternate forum ... discretionary transfers are not favored.” Xiu Feng Li v. Hock, 371 Fed.Appx. 171, 175 (2d Cir. 2010) (internal quotation marks and citations omitted). “[Ml]otions for transfer lie within the broad discretion of the district court and are determined upon notions of convenience and fairness on a case-by-case basis.” In re Cuyahoga Equip. Corp., 980 F.2d 110, 117 (2d Cir. 1992). When considering a motion to transfer, courts must “[flirst...determine whether the action sought to be transferred is one that ‘might have been brought’ in the transferee court.” In re Collins & Aikman Corp. Sec. Litig., 438 F.Supp.2d 392, 394 (S.D.N.Y. 2006) (internal citations omitted). Courts must also consider: “‘(1) the plaintiff's choice of forum, (2) the convenience of witnesses, (3) the location of relevant documents and relative ease of access to sources of proof, (4) the convenience of parties, (5) the locus of operative facts, (6) the availability of process to compel the attendance of unwilling witnesses, [and] (7) the relative means of the parties.’” D.H. Blair & Co., Inc. v. Gottdiener, 462 F.3d 95, 106-07 (2d Cir. 2006) (quoting Albert Fadem Trust v. Duke Energy Corp., 214 F.Supp.2d 341, 343 (S.D.N.Y. 2002) (“Duke Energy”)). “Courts also routinely consider judicial economy, the interest of justice, and ‘the comparative familiarity of each district with the governing law.’” Stein v. Teekay Corp., No. 3:16-CV-00345 (VAB), 2016 WL 10490287, at *1 (D. Conn. Nov. 18, 2016) (citing Synca Direct Inc. v. SCIL Animal Care Co., No. 15-CV-2332 (RJS), 2015 WL 3883281, at *1 (S.D.N.Y. June 22, 2015)).

DISCUSSION I. The District of Massachusetts is a Proper Venue Under the Securities Act, venue is proper (among other things) “in the district wherein the defendant is found or is an inhabitant or transacts business.” 15 U.S.C. § 77v(a). Tetraphase’s principal place of business and headquarters is in Watertown, Massachusetts. Compl. { 10. Individual Defendants Guy Macdonald (the Company’s Chief Executive Officer, President, and a member of its Board of Directors) and Jacques Dumas (the Company’s Chief Science Officer) are based in Tetraphase’s Watertown, Massachusetts headquarters and maintain primary residences in Massachusetts. Stahl Decl. 4. The remaining Defendants transacted business within Massachusetts by participating in the underwriting. Compl. ff 14-19 Furthermore, Venue is permitted in “a judicial district in which a substantial part of the events or omissions giving rise to the claim occurred.” 28 U.S.C. § 1391(b)(2). As explained in more detail below, a substantial part of the events allegedly giving rise to the claim occurred at Tetraphase’s headquarters. Plaintiff does not dispute that filing this case in the District of Massachusetts would have been proper. Thus, Defendants have established that the case could have been filed in the transferee court. II. Balancing Convenience and Justice A. Plaintiff's Choice of Forum Holds Little Weight Plaintiff argues that his choice to bring this action in the Southern District of New York should preclude transfer and cites Duke Energy in support. See Duke Energy Corp., 214 F. Supp. 2d at 343 (holding that “courts have typically accorded substantial weight to the first factor, plaintiff's choice of forum ... and since the law permits the suit to be brought where plaintiff has chosen to bring it, that choice should not be lightly overridden.”’)

However, Duke Energy is inapposite.’ Id. In fact, courts afford little weight to a plaintiff's choice of forum in a securities class action. See, e.g., In re Global Cash Access Holdings, Inc. Sec. Litig., No. 08 Cv.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Xiu Feng Li v. Douglas Hock and SMP Inc.
371 F. App'x 171 (Second Circuit, 2010)
Blair & Co., Inc. v. Gottdiener
462 F.3d 95 (Second Circuit, 2006)
ESPN, Inc. v. Quiksilver, Inc.
581 F. Supp. 2d 542 (S.D. New York, 2008)
Jaguar Cars, Ltd. v. National Football League
886 F. Supp. 335 (S.D. New York, 1995)
Wilson v. DIRECTBUY, INC.
821 F. Supp. 2d 510 (D. Connecticut, 2011)
Albert Fadem Trust v. Duke Energy Corp.
214 F. Supp. 2d 341 (S.D. New York, 2002)
In Re Collins & Aikman Corp. Securities Litigation
438 F. Supp. 2d 392 (S.D. New York, 2006)
In Re Hanger Orthopedic Group, Inc. Securities Litigation
418 F. Supp. 2d 164 (E.D. New York, 2006)
Warrick v. General Electric Co.
70 F.3d 736 (Second Circuit, 1995)

Cite This Page — Counsel Stack

Bluebook (online)
Garity v. Tetraphase Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/garity-v-tetraphase-pharmaceuticals-inc-nysd-2019.